Medicinal Preparations 2026 Tender

• Country: Czech Republic
• Summary: Medicinal Preparations 2026
• CZT Ref No: 134131901
• Deadline: 24 Feb 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: CZK 5500000
• Notice Type: Tender
• Document Ref. No.: 48521-2026
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• The subject of the public contract is the supply of various medicinal products for the therapy of serious acute and chronic diseases in the total expected volume of 139,264 individual doses of medicinal products. The preparations are intended for the provision of health care for medical workplaces of FN Plzeň and for dispensing in institutional pharmacies of FN Plzeň. Deliveries of the subject of performance will be carried out on the basis of the results of the completed procurement procedure for a period of four years from the signing of the purchase contract. Antimigraine containing an active ingredient eptinezumab Ampoules containing 100 mg of eptinezumab, estimated annual volume of 220 ampoules (doses); ATC N02CD05 Varium containing the active substance ethyl-telotristat P.o. form containing 250 mg ethyl telotristat per form unit, estimated annual volume 5,400 form units (doses); ATC A16AX15 An antiviral containing a combination of the active substances nirmatrelvir and ritonavir Pack containing 20 tbl containing 150 mg nirmatrelvir and 10 tbl containing 100 mg ritonavir, estimated annual volume of 100 packs (doses); ATC J05AE30 Antiasthmatic containing the active substance omalizumab Ampoule containing 150 mg of omalizumab, estimated annual volume of 800 ampoules (doses); ampoule containing 300 mg of omalizumab, estimated annual volume of 300 ampoules (doses); ATC R03DX05 Drug for therapy diseases of the biliary tract containing the active substance elafibranor P.O. a form containing 80 mg of elafibranor in a form unit, an estimated annual volume of 360 form units (doses); ATC A05AX06 Ophthalmological product containing the active substance afli...
• Documents:

 Tender Notice